bromocriptine has been researched along with Dementia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG | 1 |
| Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N | 1 |
| Hely, MA; Morris, JG; Reid, WG; Trafficante, R | 1 |
| Bódi, N; Galariotis, V; Janka, Z; Kálmán, J | 1 |
| Julien, J | 1 |
| Klawans, HL | 1 |
| Borenstein, P; Graille, D; Soret, C | 1 |
| Delwaide, PJ; Hurlet, A | 1 |
| Cooper, JA; Sagar, HJ; Sullivan, EV | 1 |
| Brisman, MH; Fetell, MR; Post, KD | 1 |
| Fujimori, M; Hattori, N; Imamura, T; Ishii, K; Takanashi, M; Yamadori, A; Yamashita, H | 1 |
| Lees, AJ; Phillips, M; Phuapradit, P; Stern, GM | 1 |
| Reid, WG | 1 |
| Harvey, NS | 1 |
| Andrew, ME; Malloy, PF; Nadeau, SE | 1 |
| Sandyk, R | 1 |
2 review(s) available for bromocriptine and Dementia
| Article | Year |
|---|---|
Frontotemporal dementia--part III. Clinical diagnosis and treatment.
Topics: Bromocriptine; Caregivers; Dementia; Diagnosis, Differential; Dopamine Agonists; Humans; Mental Status Schedule; Neuroprotective Agents; Positron-Emission Tomography; Psychometrics; Serotonin; Stress, Psychological; Tomography, Emission-Computed, Single-Photon | 2005 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
4 trial(s) available for bromocriptine and Dementia
| Article | Year |
|---|---|
Bromocriptine and buccolinguofacial dyskineasias in patients with senile dementia. A quantitative study.
Topics: Bromocriptine; Dementia; Face; Female; Humans; Movement Disorders; Placebos | 1980 |
Bromocriptine treatment for perseveration in demented patients.
Topics: Aged; Aged, 80 and over; Attention; Bromocriptine; Cognition Disorders; Dementia; Dopamine Agonists; Female; Humans; Inhibition, Psychological; Male; Middle Aged; Neuropsychological Tests; Treatment Outcome; Volition | 1998 |
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease | 1992 |
A crossover trial of bromocriptine in the treatment of vascular dementia.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dementia; Humans; Male; Middle Aged; Neuropsychological Tests | 1988 |
10 other study(ies) available for bromocriptine and Dementia
| Article | Year |
|---|---|
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis | 2011 |
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications | 2002 |
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors | 2005 |
[Dementia syndrome in depressive states. Efficacy of bromocriptine therapy].
Topics: Bromocriptine; Dementia; Depressive Disorder; Female; Humans; Middle Aged | 1982 |
Behavioral alterations and the therapy of parkinsonism.
Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced | 1982 |
[Value of bromocriptine in senile dementia].
Topics: Aged; Bromocriptine; Dementia; Electroencephalography; Humans; Middle Aged | 1981 |
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication.
Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis | 1993 |
Reversible dementia due to macroprolactinoma. Case report.
Topics: Behavior; Bromocriptine; Dementia; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1993 |
Bromocriptine in presenile dementia.
Topics: Alzheimer Disease; Bromocriptine; Dementia; Humans; Middle Aged | 1978 |
Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
Topics: Aged; Bromocriptine; Dementia; Female; Hallucinations; Humans; Parkinson Disease | 1987 |